Synthetic biology is an emerging multidisciplinary science encompassing biology, chemistry, engineering and computation. It has a broad ranging application and will impact numerous industries, especially those relating to bioprocessing, such as in the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes.
Synthetic biology has been highlighted by the Technology Strategy Board (TSB) as a priority target for investment, with the potential to create a £1B-plus industry within the next decade. Celbius has been awarded a grant worth up to £0.25M from the TSB and is actively engaged in synthetic biology projects as part of its strategic scientific direction, including working with the University of Northumbria. This will give the company access to novel technology and microbial strains that produce some key products from low cost raw materials.